https://peptide.zone/story/argenx-unnatural-products-acquisition-macrocyclic-peptidesPeptide Zoneen2026-11-10T04:52:00.000ZArgenx Unnatural Products acquisition pays 550 million dollars upfront for macrocyclic peptides https://peptide.zone/story/glp-1-vitamin-b12-supplements-optionalPeptide Zoneen2026-11-10T03:57:00.000ZGLP 1 vitamin B12 supplements optional as doctors put food and blood tests first https://peptide.zone/story/stopping-wegovy-mounjaro-gp-advice-regainPeptide Zoneen2026-11-10T03:26:00.000ZStopping Wegovy and Mounjaro advice from UK GP meets BMJ data on fast regain https://peptide.zone/story/glp-1-thanksgiving-dinner-portion-advicePeptide Zoneen2026-11-10T02:39:00.000ZGLP 1 Thanksgiving dinner advice rests on portion rules not studies https://peptide.zone/story/diabetes-group-education-injectable-hba1cPeptide Zoneen2026-11-10T01:47:00.000ZDiabetes group education for insulin and GLP 1 users tracks with lower HbA1c in 15 patient report https://peptide.zone/story/pemvidutide-mash-48-week-responder-dataPeptide Zoneen2026-11-09T04:54:00.000ZPemvidutide MASH responder data show combined liver test gains at 48 weeks